Table 7.
Sample cell-penetrating peptides and their applications in targeted and untargeted peptide delivery.
Name/Description | Sequence | Category | Outcomes of interest | Ref. |
---|---|---|---|---|
TAT | CGRKKRRQRRRPPQC | Protein derived CPP from HIV-1 | Able to deliver peptides, proteins, nanoparticles and oligonucleotides intracellularly | [222] |
Penetratin | RQIKIWFQNRRMKWKK | Protein derived CPP from Drosophila antennapedia domain | Able to deliver a variety of cargoes to many cell types | [223] |
LS-CPP | CAYHRLRRC | Dual-motif CPP | Specific delivery to leukemia cells | [221] |
Tumor prodrug CPP | EEEEEDDDDK/ARRRRRRRRR | Prodrug with tumor environment activation | Proteases in the tumor environment cleave the sequence, removing the acidic (negative) amino acid residues | [219] |
Antibody–CPP conjugate | Penetratin+MAb CC49 | MAb targeted CPP | Increased tumor: normal tissue delivery ratio | [217] |
This table contains representative CPPs that represent the major classes of targeted and untargeted CPPs. TAT and Penetratin are generally untargeted, although their biodistribution may cause site-selective accumulation. LS-CPP is a leukemia-specific CPP. The tumor prodrug CPP is cleaved at the ‘/’ when in the tumor environment, thus separating the negatively charged amino acids from the positively charged CPP-cargo conjugate. Antibody-targeted CPPs can be used to selectively deliver a CPP–cargo conjugate to desired cell types.
CPP: Cell-penetrating peptide; LS-CPP: Leukemia-specific cell-penetrating peptide; MAb: Monoclonal antibody; TAT: Trans-activating transcriptional activator.